Login / Signup

The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders.

Eva LothTony CharmanLuke MasonJulian TillmannEmily J H JonesCaroline WooldridgeJumana AhmadBonnie AuyeungClaudia BrognaSara AmbrosinoTobias BanaschewskiSimon Baron-CohenSarah BaumeisterChristian BeckmannMichael BrammerDaniel BrandeisSven BölteThomas BourgeronCarsten BoursYvette de BruijnBhismadev ChakrabartiDaisy CrawleyIneke CornelissenFlavio Dell' AcquaGuillaume DumasSarah DurstonChristine EckerJessica FaulknerVincent FrouinPilar GarcesDavid GoyardHannah HaywardLindsay M HamJoerg HippRosemary J HoltMark H JohnsonJohan IsakssonPrantik KunduMeng-Chuan LaiXavier Liogier D'ardhuyMichael V LombardoDavid J LythgoeRené MandlAndreas Meyer-LindenbergCarolin MoessnangNico MuellerLaurence O'DwyerMarianne OldehinkelBob OranjeGahan PandinaAntonio M PersicoAmber N V RuigrokBarbara RuggeriJessica SabetRoberto SaccoAntonia San José CáceresEmily SimonoffRoberto ToroHeike TostJack WaldmanSteve C R WilliamsMarcel P ZwiersWill SpoorenDeclan G M MurphyJan K Buitelaar
Published in: Molecular autism (2017)
We expect that LEAP will enable us to confirm, reject and refine current hypotheses of neurocognitive/neurobiological abnormalities, identify biologically and clinically meaningful ASD subgroups, and help us map phenotypic heterogeneity to different aetiologies.
Keyphrases
  • autism spectrum disorder
  • intellectual disability
  • attention deficit hyperactivity disorder
  • quality improvement
  • single cell
  • bipolar disorder
  • cross sectional